This NDC is on FDA's drug shortage list (posted Dec 15, 2021)

Reported reason: Shortage of an active ingredient

Product Information

METHYLPREDNISOLONE 400 MG/10 ML is a generic product labeled by Sagent Pharmaceuticals, priced at $5.8078 per ML under NDC 25021082010. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Jun 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPREDNISOLONE 400 MG/10 ML

methylprednisolone acetate
$5.8078per ML

Strength

40 mg/mL

NDC

25021082010

Classification

Generic

Dosage Form

INJECTION, SUSPENSION

Route

INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE

Effective Date

4/22/2026

Active Ingredients

METHYLPREDNISOLONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201835

FDA Approved

6/27/2018

TE Code

AB

On Market Since

11/15/2021

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for METHYLPREDNISOLONE 400 MG/10 ML has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.

Current price$5.8078 per ML
All-time high$6.5080 (Sep 10, 2025)
All-time low$5.3134 (Jun 19, 2024)
52-week high$6.5080
52-week low$5.7137
Median price$5.8749
Average price$5.9502
Largest weekly change-12.2% (Sep 17, 2025)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-1.5%

1Y

-10.8%

3Y

N/A

5Y

N/A

All

+2.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPREDNISOLONE 400 MG/10 ML?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 400 MG/10 ML, manufactured by Sagent Pharmaceuticals, is $5.8078 per ML (NDC 25021082010), effective Aug 19, 2026.

How has the price of METHYLPREDNISOLONE 400 MG/10 ML changed over time?

Over the history we have for it, the NADAC for METHYLPREDNISOLONE 400 MG/10 ML has risen 2.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 400 MG/10 ML?

Since Apr 17, 2024, the NADAC for METHYLPREDNISOLONE 400 MG/10 ML has ranged from a low of $5.3134 (Jun 19, 2024) to a high of $6.5080 (Sep 10, 2025), with a median of $5.8749 per ML.

Are there cheaper alternatives to METHYLPREDNISOLONE 400 MG/10 ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPREDNISOLONE 400 MG/10 ML in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPREDNISOLONE 400 MG/10 ML?

METHYLPREDNISOLONE 400 MG/10 ML (NDC 25021082010) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.

Is METHYLPREDNISOLONE 400 MG/10 ML in shortage?

Yes — NDC 25021082010 is currently listed in FDA's drug shortage database (posted Dec 15, 2021). Reported reason: Shortage of an active ingredient.